Organon & Co. - Common Stock (OGN)

Q3 2021 13F Holders as of 9/30/2021

Type / Class
Equity / Common Stock
Shares outstanding
260M
Number of holders
863
Total 13F shares, excl. options
167M
Shares change
-424K
Total reported value, excl. options
$5.47B
Value change
+$4.58M
Put/Call ratio
1.01
Number of buys
318
Number of sells
-600
Price
$32.79

Significant Holders of Organon & Co. - Common Stock (OGN) as of Q3 2021

1,068 filings reported holding OGN - Organon & Co. - Common Stock as of Q3 2021.
Organon & Co. - Common Stock (OGN) has 863 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 167M shares of 260M outstanding shares and own 64.16% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (28.8M shares), BlackRock Inc. (16.6M shares), STATE STREET CORP (9.02M shares), Bank of New York Mellon Corp (5.3M shares), JANUS HENDERSON GROUP PLC (5.28M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (4.9M shares), GEODE CAPITAL MANAGEMENT, LLC (4.77M shares), WELLINGTON MANAGEMENT GROUP LLP (4.37M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (4.25M shares), and Invesco Ltd. (3.21M shares).
This table shows the top 863 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.